Publisher
Springer Berlin Heidelberg
Reference39 articles.
1. AWMF Leitlinie der Deutschen Dermatologischen Gesellschaft (2016) Kutane Lyme Borreliose.
http://www.awmf.org/uploads/tx_szleitlinien/013-044l_S2k_Kutane_Lyme_Borreliose_2016-05.pdf
. zugegriffen im März 2016
2. Berende A, ter Hofstede HJ, Vos FJ et al (2016) Randomized trial of longer-term therapy for symptoms attributed to Lyme disease. N Engl J Med 374:1209–1220
3. Colli C, Leinweber B, Müllegger R et al (2004) Borrelia burgdorferi-associated lymphocytoma cutis: clinicopathologic, immunophenotypic, and molecular study of 106 cases. J Cutan Pathol 31:232–240
4. Glatz M, Resinger A, Semmelweis K et al (2015) Clinical spectrum of skin manifestations of Lyme borreliosis in 204 children in Austria. Acta Derm Venereol 95:565–571
5. Jones KL, Muellegger RR, Means TK et al (2008) Higher mRNA levels of chemokines and cytokines associated with macrophage activation in erythema migrans skin lesions in patients from the United States than in patients from Austria with Lyme borreliosis. Clin Infect Dis 46:85–92
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献